The Biotherapy International partner clinic in Germany is located in the city of Rheinfelden, near the Swiss border. Here, patients gain access to innovative cancer immunotherapy and regenerative medicine programs developed under the direction of Professor Shimon Slavin, M.D. This collaboration provides patients from Europe and around the world with access to individualized treatment based on Biotherapy International protocols.
Cancer Immunotherapy in Germany
At the partner clinic in Germany, cancer immunotherapy programs are designed for patients who require individualized treatment approaches when standard therapies have reached their limits. In Germany, innovative immunotherapies are accessible through the individual treatment framework, allowing patients to access advanced immunotherapy methods aimed at supporting their treatment course and quality of life.
Cancer Immunotherapy Methods We Utilize in Germany
- Oncolytic viruses. Human-safe oncolytic viruses that bind to tumor receptors, trigger the destruction of malignant cells, and make them recognizable to the immune system.
- Cancer vaccines. Personalized cancer vaccines that stimulate the patient’s own immune system to target and destroy cancer cells.
- ATACK. Allogeneic Targeted Activated Cancer Killer cells – intentionally mismatched cells designed to directly destroy tumors resistant to other treatments.
- Photodynamic therapy. Also known as PDT, this light-activated treatment uses photosensitizing agents to selectively damage cancer cells while sparing surrounding healthy tissue.
Cancer Types Treated with Immunotherapy in Germany
Our individualized cancer immunotherapy programs in Germany may be considered for patients with different types of advanced or recurrent cancer. The choice and combination of immunotherapy approaches depend on the tumor type, biological and molecular characteristics, previous treatment, disease extent, and the patient’s clinical condition. Treatment methods may be used alone or in combination, with the protocol selected individually after medical evaluation.
Brain tumors
Brain cancer, particularly glioblastoma, is one of Biotherapy International’s main areas of specialization. For selected patients, individualized treatment may include oncolytic virus therapy, personalized cancer vaccines, and cellular immunotherapy, with local or intrathecal administration considered when clinically appropriate.
Other Cancer Types
- Breast cancer
- Colorectal cancer
- Melanoma
- Lung cancer
- Sarcoma
- Pancreatic cancer
- Stomach cancer
- Cervical cancer
Mesenchymal Stem Cell (MSC) Therapy in Germany
Mesenchymal stem cell (MSC) therapy is used in regenerative medicine because of the cells’ immunomodulatory and regenerative properties. In Germany, MSC-based treatment may be considered for selected patients with neurodegenerative, autoimmune, and other chronic conditions.
Depending on the clinical situation, treatment may involve autologous stem cells, obtained from the patient, or allogeneic stem cells from a donor source. The choice of cell type and route of administration depends on the diagnosis, disease characteristics, previous treatment, and the patient’s overall condition.
Before treatment, medical records are reviewed to determine whether stem cell therapy may be appropriate and which approach can be considered.
Treatment is generally performed on an outpatient basis and usually requires a short stay in Germany. Follow-up recommendations depend on the condition being treated and the individual treatment protocol.
Treatment at Our Partner Clinic in Germany
Treatment programs are individually planned by Biotherapy International and carried out by the local medical team at the partner clinic in Germany, in accordance with the clinical and regulatory requirements applicable at the clinic.


